Joel Greenblatt Fibrogen Inc Transaction History

Gotham Asset Management, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$7.94 - $12.96 $85,355 - $139,320	10,750 New	10,750 $114,000
Q1 2022 May 16, 2022	SELL	$12.02 - $16.79 $470,931 - $657,815	-39,179 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$9.93 - $15.39 $389,047 - $602,964	39,179 New	39,179 $552,000
Q1 2020 May 15, 2020	SELL	$23.3 - $45.96 $759,486 - $1.5 Million	-32,596 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$34.58 - $48.06 $1.67 Million - $2.33 Million	-48,402 Reduced 59.76%	32,596 $1.4 Million
Q3 2019 Nov 14, 2019	BUY	$36.98 - $48.45 $3 Million - $3.92 Million	80,998 New	80,998 $3 Million
Q2 2019 Aug 14, 2019	SELL	$35.13 - $55.53 $434,136 - $686,239	-12,358 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$42.83 - $59.91 $340,584 - $476,404	7,952 Added 180.48%	12,358 $672,000
Q4 2018 Feb 14, 2019	BUY	$37.97 - $60.16 $167,295 - $265,064	4,406 New	4,406 $204,000

47.1M

387K

672K

Ticker FGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,741,200
Market Cap $32.8M
Description
FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...

Get notified when there are updates to the investment portfolio of Gotham Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Gotham Asset Management, LLC and Joel Greenblatt with notifications on news.